Evidence map›Paper›PMID 36872349›Full record

ReviewMilitary Medical Research2023

Applications and prospects of cryo-EM in drug discovery.

Kong-Fu Zhu, Chuang Yuan, Yong-Ming Du, Kai-Lei Sun, Xiao-Kang Zhang, Horst Vogel, Xu-Dong Jia, Yuan-Zhu Gao, Qin-Fen Zhang, Da-Ping Wang and 1 more

Abstract readReview
In one paragraph

Review in Military Medical Research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Structural Biology for Target Identification and Validation.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  19. Review
  20. Protein Structures of Urea Transporters.Sub-cellular biochemistry · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kong-Fu ZhuDepartment of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China.
Chuang YuanDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University, Beijing, 100191, China.
Yong-Ming DuDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Kai-Lei SunCenter for Protein Science and Crystallography, School of Life Sciences, Faculty of Science, Chinese University of Hong Kong, Hong Kong, 999077, China.
Xiao-Kang ZhangInterdisciplinary Center for Brain Information, the Brain Cognition and Brain Disease Institute, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, Guangdong, China.
Horst VogelShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, Guangdong, China.
Xu-Dong JiaState Key Lab for Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, 510275, China.
Yuan-Zhu GaoCryo-EM Facility Center, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China.
Qin-Fen ZhangState Key Lab for Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, 510275, China.
Da-Ping WangDepartment of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China. wangdp@mail.sustech.edu.cn.
Hua-Wei ZhangDepartment of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China. zhanghw@sustech.edu.cn.ORCID 0000-0002-5625-5809

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug discovery is a crucial part of human healthcare and has dramatically benefited human lifespan and life quality in recent centuries, however, it is usually time- and effort-consuming. Structural biology has been demonstrated as a powerful tool to accelerate drug development. Among different techniques, cryo-electron microscopy (cryo-EM) is emerging as the mainstream of structure determination of biomacromolecules in the past decade and has received increasing attention from the pharmaceutical industry. Although cryo-EM still has limitations in resolution, speed and throughput, a growing number of innovative drugs are being developed with the help of cryo-EM. Here, we aim to provide an overview of how cryo-EM techniques are applied to facilitate drug discovery. The development and typical workflow of cryo-EM technique will be briefly introduced, followed by its specific applications in structure-based drug design, fragment-based drug discovery, proteolysis targeting chimeras, antibody drug development and drug repurposing. Besides cryo-EM, drug discovery innovation usually involves other state-of-the-art techniques such as artificial intelligence (AI), which is increasingly active in diverse areas. The combination of cryo-EM and AI provides an opportunity to minimize limitations of cryo-EM such as automation, throughput and interpretation of medium-resolution maps, and tends to be the new direction of future development of cryo-EM. The rapid development of cryo-EM will make it as an indispensable part of modern drug discovery.

Indexed as

Artificial IntelligenceDrug DiscoveryCryoelectron MicroscopyHumansProteolysis Targeting ChimeraQuality of LifeProteolysis Targeting ChimeraArtificial intelligence (AI)Cryo-electron microscopy (cryo-EM)Drug discoveryDrug repurposingFragment-based drug discoveryProteolysis targeting chimerasStructure-based drug design

Identifiers

PMID36872349
PMCPMC9986049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.